HTMwire assessment
Healthcare IoT security platform with device discovery, vulnerability management, and threat detection for 900+ device types. Best in KLAS winner.
Four consecutive Best in KLAS awards for Healthcare IoT Security — widest medical device coverage with passive-only discovery that doesn't disrupt clinical workflows.
HTMwire's independent read on the technology — not the vendor's marketing claim.
Uses ML-powered deep packet inspection for passive device classification and behavioral profiling. Machine learning models baseline normal device communication patterns to detect anomalies and threats without active scanning.
Passive. Claroty discovers and classifies medical and OT devices using network-based deep packet inspection (DPI) and behavioral attributes, observing traffic rather than actively probing devices, which avoids disrupting patient-connected equipment.
Yes. Claroty xDome (formerly Medigate) was the Best in KLAS winner for Healthcare IoT Security for five consecutive years through 2025, scoring 95.4 out of 100 in the 2025 report based on 42 healthcare organizations. In the 2026 report Claroty was named a Top Performer with a 92.5 score from 35 organizations.
Claroty integrates with existing CMMS, NAC, SIEM, and firewall infrastructure, including ServiceNow, Cisco ISE, Palo Alto Networks, CrowdStrike, and Accruent TMS, so device inventory and risk data flow into the tools HTM and security teams already use.
Claroty is a well-capitalized private company. It raised a $150M Series F in January 2026 (led by Golub Growth) on top of more than $735M in prior funding, with backers including Bessemer Venture Partners, SoftBank Vision Fund 2, Rockwell Automation, Schneider Electric, and Siemens.
We cite a primary or named source for every claim on this page. How we evaluate →